What is the recommended medication regimen for an acute gout flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication for Acute Gout

For an acute gout flare, treat immediately with colchicine (1 mg loading dose followed by 0.5 mg one hour later if within 12 hours of symptom onset), OR an NSAID at full dose with a proton pump inhibitor, OR oral corticosteroids (30-35 mg/day prednisolone equivalent for 3-5 days), OR intra-articular corticosteroid injection for 1-2 large joints. 1

First-Line Treatment Options

The 2016 EULAR guidelines provide three equally effective first-line options, with selection based on contraindications and patient-specific factors 1:

Colchicine

  • Timing is critical: Only use if within 12 hours of flare onset (effectiveness drops significantly after 36 hours) 1, 2
  • Dosing: 1 mg loading dose, then 0.5 mg one hour later on day 1 1
  • Continue: 0.5 mg 2-3 times daily until flare resolves 2
  • Critical contraindications:
    • Severe renal impairment (GFR <30 mL/min) 1
    • Concurrent use of strong P-glycoprotein/CYP3A4 inhibitors (cyclosporin, clarithromycin, erythromycin, verapamil, ketoconazole) 1
    • Reduce dose in moderate CKD and patients on statins due to neurotoxicity/myotoxicity risk 1
  • Warning sign: Diarrhea is the first symptom of colchicine toxicity—reduce dose immediately 3

NSAIDs

  • Any NSAID at full approved dose (no single NSAID is superior) 2
  • Add proton pump inhibitor if gastrointestinal risk factors present 1
  • Continue at full dose until flare completely resolves 2
  • Contraindications: Severe renal impairment, heart failure, cirrhosis, active peptic ulcer disease 1, 4

Corticosteroids

  • Oral: Prednisolone 30-35 mg/day for 3-5 days, then stop (or taper over 7-10 days) 1, 2
  • Intra-articular: For 1-2 large joints—dose based on joint size, can combine with oral agents 2
  • Intramuscular: Triamcinolone acetonide 60 mg as alternative 2
  • Advantage: Generally safer than NSAIDs with fewer adverse effects, making them preferred first-line in patients with multiple comorbidities 4

Treatment Algorithm

Step 1: Assess timing

  • If <12 hours from onset AND no contraindications → Colchicine preferred
  • If >12-36 hours → Colchicine still option but less effective
  • If >36 hours → Choose NSAID or corticosteroid 2

Step 2: Screen for contraindications

  • Severe CKD (GFR <30) → Use corticosteroids (avoid colchicine and NSAIDs) 1
  • Heart failure/cirrhosis → Use corticosteroids or colchicine (avoid NSAIDs)
  • On cyclosporin/clarithromycin → Avoid colchicine 1
  • GI bleeding history → Use corticosteroids or colchicine with PPI (caution with NSAIDs)

Step 3: Consider severity

  • Monoarticular (1-2 joints) → Any single agent
  • Polyarticular or severe → Combination therapy is appropriate: colchicine + NSAID, or colchicine + corticosteroid, or intra-articular + any oral agent 2, 1
  • Do NOT combine NSAIDs with systemic corticosteroids (synergistic GI toxicity) 2

Second-Line Treatment

IL-1 blockers (anakinra, canakinumab) should be considered when colchicine, NSAIDs, and corticosteroids are all contraindicated, ineffective, or not tolerated 1. These are particularly useful in patients with frequent flares and multiple contraindications 1. Contraindication: Active infection 1.

Critical Pitfalls to Avoid

  1. Do not delay treatment: Early intervention (ideally within 12 hours) dramatically improves outcomes. Educate patients to self-medicate at first warning symptoms 1

  2. Colchicine drug interactions are dangerous: Fatal toxicity can occur with P-glycoprotein/CYP3A4 inhibitors. Always check medication list 1, 2

  3. Dose adjustment in renal impairment is mandatory: Both colchicine and NSAIDs require adjustment or avoidance in CKD 1, 2

  4. Do not start or stop urate-lowering therapy during acute flare: Continue existing ULT but don't initiate new ULT until discussing with patient (though starting during flare is acceptable if decision made) 5

  5. Screen for cardiovascular risk factors and comorbidities: Renal impairment, coronary disease, heart failure, hypertension, diabetes all influence drug selection 1

Patient Education Priority

Patients must understand that acute flare treatment is separate from long-term urate-lowering therapy. They should have a pre-defined treatment plan to self-administer at the first sign of a flare 1, 3. The "pill in the pocket" approach significantly improves outcomes 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.